相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells
Yan Hu et al.
ANTI-CANCER DRUGS (2017)
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells
Matthias R. Bauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
Masatsugu Hiraki et al.
CHEMISTRY & BIOLOGY (2015)
Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor
Esha Madan et al.
Oncotarget (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer
Kellie S. Rath et al.
CANCER RESEARCH (2014)
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Susann Weissmueller et al.
CELL (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Non-Cell-Autonomous Tumor Suppression by p53
Amaia Lujambio et al.
CELL (2013)
p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys118 acetylation
Rajan Gogna et al.
EMBO MOLECULAR MEDICINE (2013)
SCO2 Induces p53-Mediated Apoptosis by Thr845 Phosphorylation of ASK-1 and Dissociation of the ASK-1-Trx Complex
Esha Madan et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Preferential Binding of Hot Spot Mutant p53 Proteins to Supercoiled DNA In Vitro and in Cells
Marie Brazdova et al.
PLOS ONE (2013)
A p38mapk-p53 cascade regulates mesodermal differentiation and neurogenesis of embryonic stem cells
Y. Hadjal et al.
CELL DEATH & DISEASE (2013)
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis
P. Yang et al.
SCIENTIFIC REPORTS (2013)
p53 DNA Binding Cooperativity Is Essential for Apoptosis and Tumor Suppression In Vivo
Oleg Timofeev et al.
CELL REPORTS (2013)
p53 Ser15 phosphorylation disrupts the p53-RPA70 complex and induces RPA70-mediated DNA repair in hypoxia
Esha Madan et al.
BIOCHEMICAL JOURNAL (2012)
TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex
E. Madan et al.
BRITISH JOURNAL OF CANCER (2012)
HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells
Brent J. Tierney et al.
CANCER BIOLOGY & THERAPY (2012)
Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression
Rajan Gogna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting Mutant p53 in Human Tumors
Brian D. Lehmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
Soren Lehmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
Rainer Wilcken et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Re-oxygenation causes hypoxic tumor regression through restoration of p53 wild-type conformation and post-translational modifications
R. Gogna et al.
CELL DEATH & DISEASE (2012)
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S. Coates et al.
BREAST CANCER RESEARCH (2012)
Cancer-associated p53 Tetramerization Domain Mutants QUANTITATIVE ANALYSIS REVEALS A LOW THRESHOLD FOR TUMOR SUPPRESSOR INACTIVATION
Rui Kamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia
Martin Trbusek et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation
Jennifer J. Jordan et al.
MOLECULAR CANCER RESEARCH (2010)
HO-3867, a Synthetic Compound, Inhibits the Migration and Invasion of Ovarian Carcinoma Cells through Downregulation of Fatty Acid Synthase and Focal Adhesion Kinase
Karuppaiyah Selvendiran et al.
MOLECULAR CANCER RESEARCH (2010)
Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts
Karuppaiyah Selvendiran et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mutant p53 mediates survival of breast cancer cells
L. Y. Lim et al.
BRITISH JOURNAL OF CANCER (2009)
PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
Jeremy M. R. Lambert et al.
CANCER CELL (2009)
Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions
D. Walerych et al.
ONCOGENE (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells
Adrian Staab et al.
BMC CANCER (2007)
Reactivation of mutant p53: molecular mechanisms and therapeutic potential
G. Selivanova et al.
ONCOGENE (2007)
P53 is preferentially recruited to the promoters of growth arrest genes p2l and GADD45 during replicative senescence of normal human fibroblasts
James G. Jackson et al.
CANCER RESEARCH (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
F Toledo et al.
CANCER CELL (2006)
NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro
M Krajewski et al.
NATURE MEDICINE (2005)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation
MC Thomas et al.
MOLECULAR CELL (2005)
How many mutant p53 molecules are needed to inactivate a tetramer?
WM Chan et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death
J Wischhusen et al.
ONCOGENE (2003)
p53 Mutations and survival in stage I non-small-cell lung cancer: Results of a prospective study
SA Ahrendt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Characterization of the p53-rescue drug CP-31398 in vitro and in living cells
TM Rippin et al.
ONCOGENE (2002)
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
D Kirn
GENE THERAPY (2001)
分享论文
